UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 165

Sortiert nach

Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors

ACS omega, 2023-01, Vol.8 (2), p.2445-2454

2023

Volltextzugriff (PDF)

Quinazoline-4(3H)‑one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5‑Lipoxygenase Activating Protein Inhibition

ACS omega, 2022-10, Vol.7 (41), p.36354-36365

2022

Volltextzugriff (PDF)

Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity

ACS omega, 2022-10, Vol.7 (41), p.36206-36226

2022

Volltextzugriff (PDF)

Healthcare personnel's attitude and coverage about tetanus vaccination in Turkey: a multicenter study

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.2014732-2014732

2022

Volltextzugriff (PDF)

Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis

European journal of medicinal chemistry, 2018-06, Vol.153, p.34-48

2018

Volltextzugriff (PDF)

Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells

European journal of medicinal chemistry, 2021-10, Vol.221, p.113489-113489, Article 113489

2021

Volltextzugriff (PDF)

Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents

Journal of enzyme inhibition and medicinal chemistry, 2018-01, Vol.33 (1), p.1352-1361

2018

Volltextzugriff (PDF)

Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase

European journal of medicinal chemistry, 2022-03, Vol.231, p.114167-114167, Article 114167

2022

Volltextzugriff (PDF)

Discovery and Optimization of Piperazine Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors

ChemMedChem, 2022-06, Vol.17 (12), p.e202200137-n/a

2022

Volltextzugriff (PDF)

Synthesis and preliminary mechanistic evaluation of 5-(p-tolyl)-1-(quinolin-2-yl)pyrazole-3-carboxylic acid amides with potent antiproliferative activity on human cancer cell lines

European journal of medicinal chemistry, 2014-11, Vol.87, p.140-149

2014

Volltextzugriff (PDF)

A Multi‐step Virtual Screening Protocol for the Identification of Novel Non‐acidic Microsomal Prostaglandin E2 Synthase‐1 (mPGES‐1) Inhibitors

ChemMedChem, 2019-01, Vol.14 (2), p.273-281

2019

Volltextzugriff (PDF)

Evaluation of Cytotoxic Activity of New Benzimidazole-Piperazine Hybrids Against Human MCF-7 and A549 Cancer Cells

Pharmaceutical chemistry journal, 2020-02, Vol.53 (11), p.1036-1046

2020

Volltextzugriff (PDF)

Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors

Archiv der Pharmazie (Weinheim), 2022-08, Vol.355 (8), p.e2200082-n/a

2022

Volltextzugriff (PDF)

Antimigratory effect of pyrazole derivatives through the induction of STAT1 phosphorylation in A549 cancer cells

Journal of pharmacy and pharmacology, 2021-04, Vol.73 (6), p.808-815

2021

Volltextzugriff (PDF)

4,5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP)

European journal of medicinal chemistry, 2016-05, Vol.113, p.1-10

2016

Volltextzugriff (PDF)

Identification of multi-target inhibitors of leukotriene and prostaglandin E2 biosynthesis by structural tuning of the FLAP inhibitor BRP-7

European journal of medicinal chemistry, 2018-04, Vol.150, p.876-899

2018

Volltextzugriff (PDF)

Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors

Bioorganic chemistry, 2024-06, Vol.147, p.107383-107383, Article 107383

2024

Volltextzugriff (PDF)

Benzimidazole derivatives as potent and isoform selective tumor-associated carbonic anhydrase IX/XII inhibitors

Bioorganic chemistry, 2020-01, Vol.95, p.103544-103544, Article 103544

2020

Volltextzugriff (PDF)

Overview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors

Expert opinion on drug discovery, 2013-01, Vol.8 (1), p.49-63

2013

Volltextzugriff (PDF)

Chromatographic separation and biological evaluation of benzimidazole derivative enantiomers as inhibitors of leukotriene biosynthesis

Journal of pharmaceutical and biomedical analysis, 2014-02, Vol.89, p.88-92

2014

Volltextzugriff (PDF)

BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly

Biochemical pharmacology, 2016-11, Vol.119, p.17-26

2016

Volltextzugriff (PDF)

Pyrazol-3-propanoic acid derivatives as novel inhibitors of leukotriene biosynthesis in human neutrophils

European journal of medicinal chemistry, 2011-10, Vol.46 (10), p.5021-5033

2011

Volltextzugriff (PDF)

HLA Genotypes in Turkish Hematopoietic Cell Recipients and Likelihood of Finding a Matched Donor Through Family Searches

Experimental and clinical transplantation, 2019-12, Vol.17 (6), p.813-818

2019

Volltextzugriff (PDF)

Synthesis, antioxidant and antimicrobial evaluation of simple aromatic esters of ferulic acid

Archives of Pharmacal Research, 2011, 34(8), , pp.1251-1261

2011

Volltextzugriff (PDF)

Simple heteroaryl modifications in the 4,5-diarylisoxazol-3-carboxylic acid scaffold favorably modulates the activity as dual mPGES-1/5-LO inhibitors with in vivo efficacy

Bioorganic chemistry, 2021-07, Vol.112, p.104861-104861, Article 104861

2021

Volltextzugriff (PDF)

1 – 25 von 165

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(149)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors

Quinazoline-4(3H)‑one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5‑Lipoxygenase Activating Protein Inhibition

Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity

Healthcare personnel's attitude and coverage about tetanus vaccination in Turkey: a multicenter study

Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis

Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells

Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents

Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase

Discovery and Optimization of Piperazine Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors

Synthesis and preliminary mechanistic evaluation of 5-(p-tolyl)-1-(quinolin-2-yl)pyrazole-3-carboxylic acid amides with potent antiproliferative activity on human cancer cell lines

A Multi‐step Virtual Screening Protocol for the Identification of Novel Non‐acidic Microsomal Prostaglandin E2 Synthase‐1 (mPGES‐1) Inhibitors

Evaluation of Cytotoxic Activity of New Benzimidazole-Piperazine Hybrids Against Human MCF-7 and A549 Cancer Cells

Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors

Antimigratory effect of pyrazole derivatives through the induction of STAT1 phosphorylation in A549 cancer cells

4,5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP)

Identification of multi-target inhibitors of leukotriene and prostaglandin E2 biosynthesis by structural tuning of the FLAP inhibitor BRP-7

Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors

Benzimidazole derivatives as potent and isoform selective tumor-associated carbonic anhydrase IX/XII inhibitors

Overview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors

Chromatographic separation and biological evaluation of benzimidazole derivative enantiomers as inhibitors of leukotriene biosynthesis

BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly

Pyrazol-3-propanoic acid derivatives as novel inhibitors of leukotriene biosynthesis in human neutrophils

HLA Genotypes in Turkish Hematopoietic Cell Recipients and Likelihood of Finding a Matched Donor Through Family Searches

Synthesis, antioxidant and antimicrobial evaluation of simple aromatic esters of ferulic acid

Simple heteroaryl modifications in the 4,5-diarylisoxazol-3-carboxylic acid scaffold favorably modulates the activity as dual mPGES-1/5-LO inhibitors with in vivo efficacy

Suchergebnisse filtern